Cover Image

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

Jesse D Ortendahl,1 Sonia J Pulgar,2 Beloo Mirakhur,3 David Cox,3 Tanya GK Bentley,1 Alexandria T Phan4 1Health Economics, Partnership for Health, LLC, Beverly Hills, CA, USA; 2Health Economics and Outcomes Research, Ipsen Biopharmaceuticals, Basking Ridge, NJ, USA; 3Medical Affairs, Oncology, Ipsen...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ortendahl JD (Author), Pulgar SJ (Author), Mirakhur B (Author), Cox D (Author), Bentley TGK (Author), Phan AT (Author)
Format:	Book
Published:	Dove Medical Press, 2017-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
by: Huiying Shi, et al.
Published: (2020)

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors
by: Paragliola RM, et al.
Published: (2016)

Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
by: José Manuel Lopes
Published: (2017)

Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
by: Christina Darden, et al.
Published: (2021)

Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models
by: Kenta Kawasaki, et al.
Published: (2018)

<sup>225</sup>Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic
by: Léa Rubira, et al.
Published: (2023)

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
by: Wolin EM, et al.
Published: (2015)

Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
by: Valentina Rossi, et al.
Published: (2019)

Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells
by: Valentina Rossi, et al.
Published: (2024)

Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis
by: Michelle H. Gurel, et al.
Published: (2017)

Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review
by: Anna La Salvia, et al.
Published: (2021)

Metastatic pulmonary tumor from type 3 gastric neuroendocrine tumor
by: Shuta Ohara, et al.
Published: (2021)

Signet ring: A rare morphology of metastatic neuroendocrine tumor
by: Manoj G Madakshira, et al.
Published: (2019)

Somatostatin analog (octreotide) and sirolimus immunosuppressive therapy in the treatment of chyloperitoneum and chylothorax in newborns and infants
by: Aleksandra Gurskaya, et al.
Published: (2024)

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
by: Bharmal M, et al.
Published: (2019)

Metastatic well-differentiated neuroendocrine tumor in the breast: A case report and literature review
by: Dongfang Yu, et al.
Published: (2019)

Neuroendocrine Tumor
Published: (2012)

Chronic venulectasias secondary to persistent flushing in the setting of a metastatic well-differentiated neuroendocrine tumor
by: Eleanor M. Pope, BA, et al.
Published: (2022)

Metastatic follicular thyroid carcinoma with clear cell component mimicking neuroendocrine tumor: Case report
by: Hector Chavarria, et al.
Published: (2021)

Chilean experience using "Theranostics" for treating metastatic neuroendocrine tumors with [177Lu]Lu DOTA-TATE
by: Horacio Amaral, et al.
Published: (2020)

Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic gastric mixed neuroendocrine-non-neuroendocrine tumor: a case report
by: Lingnan Zheng, et al.
Published: (2024)

Somatostatin in inflammatory bowel disease
by: J. D. Van Bergeijk, et al.
Published: (1997)

Neuroendocrine tumors of the vagina
by: S. O. Nikogosyan, et al.
Published: (2015)

Neuroendocrine Tumors in Pediatrics
by: Zainab Azam Farooqui, et al.
Published: (2019)

Advanced metastatic pancreatic neuroendocrine tumor treated successfully with peptide receptor radionuclide therapy: a case report
by: Amit Kumar, et al.
Published: (2022)

Budget impact of eribulin in metastatic breast cancer in Russian Federation
by: S. K. Zyryanov, et al.
Published: (2018)

Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
by: Juday T, et al.
Published: (2013)

A rare case of neuroendocrine carcinoma of the endometrium metastatic to the thyroid
by: Nancy Zhou, et al.
Published: (2021)

A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers
by: Golor G, et al.
Published: (2012)

Pancreatic neuroendocrine tumors: classification, diagnosis and treatment - A review of the most frequent neuroendocrine tumors
by: Dominika Karolina Adamiec, et al.
Published: (2024)

Neuroendocrine Tumor, diagnostic difficulties
by: Pedro Oliveira, et al.
Published: (2017)

Imaging in Pancreatic Neuroendocrine Tumors
by: Savinay Kapur, et al.
Published: (2020)

Diagnosis of Pancreatic Neuroendocrine Tumors
by: Dong Wook Lee, et al.
Published: (2017)

Neuroendocrine tumor in horseshoe kidney
by: Anand Ajay, et al.
Published: (2010)

Head-to-Head Comparison of SSTR Antagonist [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>-LM4 with SSTR Agonist [<sup>68</sup>Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study
by: Rahul Viswanathan, et al.
Published: (2024)

A pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) (NET and undifferentiated carcinoma of the pancreas with osteoclast-like giant cells) with metastatic neuroendocrine component to the liver
by: Guofeng Gao, et al.
Published: (2021)

Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity
by: Papadimitriou John C, et al.
Published: (2007)

Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary
by: Merijn CF Mulders, et al.
Published: (2024)

The Balanced Budget Act of 1997 and U.S. Hospital Operations
by: Gloria J. Bazzoli, et al.
Published: (2004)

Diagnosis and Management of Rectal Neuroendocrine Tumors
by: Shreya Chablaney, et al.
Published: (2017)